Basilea Pharmaceutica AG (BSLN) — Free Cash Flow Generation Index
Basilea Pharmaceutica AG (BSLN) has a Free Cash Flow Generation Index of 0.94x as of December 2025. Free cash flow of CHF36.73 Million represents 1% of operating cash flow (CHF39.03 Million). Read Basilea Pharmaceutica AG debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Basilea Pharmaceutica AG Free Cash Flow Generation Index (2005–2025)
Historical FCF Generation Index trend for Basilea Pharmaceutica AG across 8 annual periods. Explore capital reinvestment ratio of Basilea Pharmaceutica AG to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Basilea Pharmaceutica AG (2005–2025)
Year-by-year Free Cash Flow Generation Index for Basilea Pharmaceutica AG. For the full company profile including market capitalisation, see Basilea Pharmaceutica AG (BSLN) total market value.
| Year | FCG Index | Free Cash Flow (CHF) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.96x | CHF59.47 Million | CHF62.09 Million | CHF2.62 Million | ▼ -2.0% |
| 2024 | 0.98x | CHF72.65 Million | CHF74.36 Million | CHF1.71 Million | ▲ +5.3% |
| 2023 | 0.93x | CHF13.21 Million | CHF14.24 Million | CHF1.03 Million | ▲ +74.4% |
| 2022 | 0.53x | CHF3.75 Million | CHF7.06 Million | CHF3.30 Million | ▼ -44.7% |
| 2017 | 0.96x | CHF18.30 Million | CHF19.01 Million | CHF711.00K | ▼ -2.9% |
| 2012 | 0.99x | CHF146.85 Million | CHF148.17 Million | CHF1.32 Million | ▲ +0.3% |
| 2010 | 0.99x | CHF105.40 Million | CHF106.64 Million | CHF1.24 Million | ▲ +2.4% |
| 2005 | 0.97x | CHF33.18 Million | CHF34.38 Million | CHF1.20 Million | — |